Antineutrophil cytoplasmic antibodies

Bulletin on the Rheumatic Diseases

Volumn 47, Issue 6, 1998, Pages 5-8

  Hoffman, Gary S ^a   Specks, Ulrich ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; BLOOD; HUMAN; IMMUNOLOGY; PHYSIOLOGY; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0032186118     PISSN: 00075248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lüdemann J, Utecht B, Gross WL: Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 71:357-362,1990.
2. Jennette JC, Hoidal JR, FaLk RJ: Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75:2263-2264, 1990.
3. Niles JL, Ahmad MR, McCluskey RT, Arnaout MA: Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75:2264, 1990.
4. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 25:1651-1657, 1988.
5. Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, et al: Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 33:1264-1272, 1990.
6. Gaskin G, Savage COS, Jones RS, Rees AJ, Lockvood CM, Pusey CD: Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6:689-694, 1991.
7. Specks U, Wiegert EM, Homburger HA: Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 109: 286-295, 1997.
8. N̈lle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL: Anticytoplasmic autoantibodies: their immunodiagnostic value. Ann Int Med 111:28-40, 1989.
9. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS: Limited frognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36:365-371, 1993.
10. Falk RJ, Hogan S, Carey TS, Jennette ]C, Network GDC: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 113:656-663, 1990.
11. Jennette JC, Falk RJ, Andrassy K, Bacon BA, Churg J, Gross WL, et al: Nomenclature of systemic vasculitides: The proposal of an international consensus conference. Arthritis Rheum 37:187-192, 1994.
12. Guillevin L, Visser H, Noel LH, Pourrat J, Vernier I, Gayraud M, et al: Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome - 62 patients. J Rheumatol 20:1345-1349, 1993.
13. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126:866-873, 1997.
14. Helsloot J, Virgo S, McGuigan L, Sturgess A: Antineutrophil cytoplasmic antibodies in inflammatory arthritis-potential for misdiagnosis. Br J Rheumatol 34:820-824, 1995.
15. Davenport A, Lock RJ, Wallington TB: Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms. Thorax 49:213- 217, 1994.
16. Heeringa P, Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM: Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidnery Intern 53: 253-263, 1998.
17. Langford CA: The diagnostic utility of cANCA in Wegener's granulomatosis. Cleve Clin J Med 65:135-140, 1998.